Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients
Background. Nicorandil in reducing contrast-induced nephropathy (CIN) following elective percutaneous coronary intervention (PCI) is an inconsistent practice. This article aims to evaluate the efficacy and safety of nicorandil in preventing CIN after elective PCI. Methods. This is a pooled analysis...
Saved in:
Main Authors: | Bin Yi, Shaoyan Mo, Yumei Jiang, Dingwu Yi, Jinwen Luo, Xiang Chen, Jian Rong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Interventional Cardiology |
Online Access: | http://dx.doi.org/10.1155/2020/4527816 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
by: Sana Shoukat, et al.
Published: (2010-01-01) -
Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention
by: Zhebin You, et al.
Published: (2019-01-01) -
The Agatston score is a predictor of contrast-induced nephropathy in patients with stable coronary artery disease after percutaneous coronary intervention
by: Fatih Sivri, et al.
Published: (2024-11-01) -
Elevation of preoperative cystatin C as an early predictor of contrast-induced nephropathy in patients receiving percutaneous coronary intervention
by: Guoqiang Gu, et al.
Published: (2022-08-01) -
Association between the triglyceride-glucose index and contrast-induced nephropathy in chronic total occlusion patients undergoing percutaneous coronary intervention
by: Serdar Söner, et al.
Published: (2025-01-01)